Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism HPK1 inhibitors(Mitogen-activated protein kinase kinase kinase kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Regor Therapeutics GroupStartup |
Active Organization Regor Therapeutics GroupStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colonic Cancer | Preclinical | US | Regor Therapeutics GroupStartup | 01 Dec 2021 |